Device Trial Radar · NCT02912507
Split-tattoo Study Comparing the Safety and Efficacy of 670nm Picosecond Laser Versus 755 nm for Tattoo Removal
Last checked: Nov 20, 2026Latest source record: Oct 4, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
11
Actual
Start
Sep 9, 2016
Primary completion
Aug 16, 2017
Study completion Aug 16, 2017
Sponsor
- Lead sponsor
- Cutera Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 23, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Study to evaluate safety and efficacy of treatment with the investigational Cutera enlighten laser for tattoo removal as compared to treatment with the Cynosure PicoSure laser
Conditions
- Tattoo Removal
Interventions
Cutera enlighten laserDevice
high-powered, Q-switched 670nm Picosecond laser system indicated for tattoo removal
CynoSure PicoSure 755nm laserDevice
high-powered, Q-switched Alexandrite system that delivers laser energy in the 755 nm wavelength and has received FDA clearance (K133364) for tattoo and benign pigmented lesion removal.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Degree of Tattoo Clearing as Assessed by the Investigator (Physician's Global Assessment of Improvement)Time frame: 6 weeks post-final treatment, an average of 8 months from baseline
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Laser Skin Solutions Jacksonville
Jacksonville Beach, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.